BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

Low molecular weight heparin (LMWH) is an anticoagulant injected subcutaneously or intravenously and acts via activation of antithrombin III which in turn inactivates thrombin and factor Xa to ...

SAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and ...

Lovenox and heparin are injectable medications used to prevent and treat blood clots. However, Lovenox is a type of ...

There are two formulations of heparins, unfractionated heparin (UFH) and low molecular weight heparin (LMWH), used in clinical practice. Unfractionated heparin is used for both therapeutic ...

For patients undergoing elective hip- and knee-replacement surgery, the current options for prophylaxis of VTE include low-molecular-weight heparin, warfarin or pentasaccharide. Guidelines advise ...

Opens in a new tab or window SAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and low-molecular-weight heparin (LMWH) injections as a bleeding ...